← Back to all trials
Active Not Recruiting
NCT05631080
Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer
Conditions: Prostate Cancer Stage I, Bladder Outlet Obstruction
Sex: Male
Ages: 18 Years – N/A
Phase: PHASE4
Enrollment: 50
Sponsor: Mansoura University
Location: Egypt
Summary
We will compare oncological and functional outcomes of anatomical endoscopic enucleation of the prostate (AEEP) versus continued medical treatment in low-risk prostate cancer patients for whom an active surveillance protocol was selected.
Eligibility Criteria
Inclusion Criteria:Life expectancy >/= 10 yearsLow risk prostate cancer with minor institutional amendment of EAU guidelines:PSA < 10 ng/ml or up to 20 ng/ml if PSA density is more than 15%Stage T1, T2a.Gleason score <7 (ISUP grade 1)Bladder outlet obstruction:IPSS > 9Peak flow rate (Qmax < 15)Imperative indication for BOO surgeryExclusion criteria:Patients who are not willingPatients with bladder dysfunction (cystopathy) or other infravesical cause of obstruction other than prostate
Source: ClinicalTrials.gov (NCT05631080). StuddyBuddy aggregates publicly available trial information.
